Status:
COMPLETED
Assessing the Effectiveness of Acceptance and Commitment Therapy for Distress Following Psychosis
Lead Sponsor:
University of Glasgow
Collaborating Sponsors:
NHS Greater Glasgow and Clyde
Conditions:
Psychosis
Schizophrenia
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
This research investigates a new talking therapy aimed at helping people to come to terms with the experience of psychosis. The new therapy is called Acceptance and Commitment Therapy for psychosis (P...
Detailed Description
Emphasis has been placed on treating the 'positive symptoms' of psychosis (e.g. hallucinations and delusions). Concordance rates with anti-psychotic medication can be low. Even when positive symptoms ...
Eligibility Criteria
Inclusion
- Participants will meet DSM-IV-TR (APA, 2000) criteria for a psychotic disorder determined by a diagnosis of a psychotic disorder (i.e., Schizophrenia, Schizoaffective Disorder, Schizophreniform Disorder, Delusional Disorder, Brief Psychotic Disorder, Psychotic Disorder NOS) or Bipolar Disorder (with psychotic features).
- Participants will also be aged 18-65
Exclusion
- Participants will be excluded if there is a
- diagnosis of learning disability
- inability to participate in psychotherapy/research due to acute medical condition or florid psychosis (as defined by a score of 5 or over on the Positive Syndrome scale of the PANSS)
- psychotic symptoms due to a general medical condition
- they are receiving a systematic psychological therapy at the point of recruitment/randomization.
Key Trial Info
Start Date :
October 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 1 2010
Estimated Enrollment :
27 Patients enrolled
Trial Details
Trial ID
NCT01003132
Start Date
October 1 2009
End Date
October 1 2010
Last Update
November 9 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Greater Glasgow and Clyde NHS
Glasgow, Scotland, United Kingdom, G3 8YZ